Prescription Drug Trends

Express Scripts has been actively and passionately involved in doing in-depth research on prescription drug spending…Read More

Our Drug Trend Report provides the healthcare industry’s most detailed analysis of prescription drug costs and utilization. Our clients — the health plans, employers, unions and government agencies that provide benefits — have a vested interest in tracking how medication costs shift from year to year, and we want to extend this knowledge to consumers and the health community.

Current Prescription Drug Spending
Over the last five years, one pattern has consistently emerged: growth in drug spend has slowed. In 2011, the country spent 2.7% more on prescription drugs than it did in 2011, which is the lowest increase Express Scripts has ever recorded in its eighteen years of tracking the statistic.

Market Factors vs. Behavioral Factors
We’ve divided components of prescription drug spending into two groups: market factors and behavioral factors.

Market factors refer to supply side forces within the prescription market as well as changes in the prevalence of disease. These include:

  • Prevalence
  • Cost per unit
  • Units per prescription
  • Patent expirations
  • New drugs

Behavioral factors focus on whether patients are taking medications and which medications they are taking. These include:

  • Intensity (i.e., adherence)
  • Mix (i.e., use of generics vs brand-name drugs)

In this section, we’ll take a closer look at insights from the 2011 Drug Trend Report and discussing what that means for the industry in 2012 and moving forward.

Prescription Drug Trends

Geography of ADD Treatment Is Dynamic

ADD_Ex3_150x150

  |  

The South still leads the nation in terms of percentages of people diagnosed and people treated for attention deficit disorders, but the Northeast has the highest growth rate for diagnosis, treatment and total associated costs. These are the findings of Express Scripts research into three years of data related to claims for drugs treating ADD …

Read More

Prescription Drug Trends

Specialty Drug Spending to Jump 67% by 2015

Estimated Specialty Drug Trend For 2013-2015

  |  

U.S. spending on specialty prescription drugs — those used to treat chronic, complex diseases such as cancer, multiple sclerosis and rheumatoid arthritis — is projected to increase 67% by the end of 2015, according to a forecast released today by Express Scripts. As we see what’s on the horizon, it’s time for employers and health …

Read More

Prescription Drug Trends

Controlling Utilization Key for Workers’ Comp

WCDTR_logo_150x150

  |  

Narcotics make up more than one-third of workers’ compensation pharmacy expenses and also have a high potential for dependency. Express Scripts helped workers’ compensation payers reduce the use of narcotics and other medications commonly used to treat work-related injuries last year, according to the Express Scripts 2012 Workers’ Compensation Drug Trend Report. Narcotics a Significant Class  …

Read More

Prescription Drug Trends

20/20 Vision: Researching Healthcare’s Future

2020 Vision

  |  

Despite what your grandmother may tell you, curiosity isn’t always a bad thing. Without it, we wouldn’t have the life-saving medications we do today, or the technology that keeps us informed and entertained. Or, in our case, the information that fuels the benefit design decisions we make. At Express Scripts, we’re a mighty curious bunch. We knew …

Read More

Prescription Drug Trends

2013: Another Big Year Likely for Drug Approvals

FDA2013_150x150

  |  

As I discussed in my post yesterday, 2012 was a landmark year for drug approvals. It turns out that 2013 is shaping up to be nearly as big. We could easily see more than 30 new drugs approved, and I expect the ratio to follow recent years, with 60% being specialty medications. Specialty drugs to treat …

Read More